A new genotyping tool for detecting inversions in the human genome potentially associated with disease is being developed by the comparative and functional genomics group of the Universitat Autònoma de Barcelona (UAB). Together with the UAB Technology Transfer Office, the team is now looking to commercialize the approach and expand its use to many indications.
From the publishers of Nature, the BioPharma Dealmakers website brings together life sciences companies and individuals looking to identify and attract partners and dealmaking opportunities. It provides insights into dealmaking trends from BioPharma Dealmakers Editors, profiles from companies looking to partner, tools for networking and sharing knowledge, and the opportunity for sponsoring companies to showcase their expertise. BioPharma Dealmakers is THE destination for partnering professionals looking to make connections and get the latest on their industry.